NCT04286282View on ClinicalTrials.gov

Neuroinflammation and Modulating Factors in Depression and HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

November 9, 2023

Study Completion Date

April 9, 2024

Conditions
DepressionHIV
Interventions
BEHAVIORAL

Group Pyschotherapy

Group psychotherapy

OTHER

Depression Standard of Care

Standard clinical care for depression, which may include the use of selective serotonin re-uptake inhibitors (SSRIs).

OTHER

HIV Standard of Care

Standard clinical care for HIV

Trial Locations (1)

Unknown

Infectious Diseases Institute, Kampala

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Minnesota

OTHER

NCT04286282 - Neuroinflammation and Modulating Factors in Depression and HIV | Biotech Hunter | Biotech Hunter